| Patents for C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122) |
|---|
| 07/28/2011 | US20110183959 P38 kinase inhibiting agents |
| 07/21/2011 | US20110178122 Quinolizidinone M1 Receptor Positive Allosteric Modulators |
| 07/20/2011 | CN102126987A Chiral allylamine compounds and synthesis method and applications thereof |
| 07/20/2011 | CN101484190B Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents |
| 07/13/2011 | CN102120742A Preparation method of 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a] quinolizidine-2-ketone |
| 07/06/2011 | EP2340247A1 Quinolizidinone m1 receptor positive allosteric modulators |
| 07/06/2011 | CN102114411A Lecithin magnetic nano-composite and preparation method and application thereof |
| 06/30/2011 | WO2011078030A1 Chromene compound |
| 06/30/2011 | US20110160238 Octahydroquinolizines for antidiabetic treatment |
| 06/28/2011 | US7968716 Caspase inhibitors and uses thereof |
| 06/28/2011 | US7968564 HIV integrase inhibitors |
| 06/28/2011 | CA2635196C Glucocorticoid receptor modulators |
| 06/23/2011 | US20110152220 Methods of diagnosing, preventing and treating bone mass diseases |
| 06/22/2011 | CN1900076B Tetrahydro proto-berberine compounds, and their preparing method and use |
| 06/22/2011 | CN101121714B Method for synthesizing 3-(2-phenylethyl)-5-[2,3,6,7-tetrahydro-1H,5H-benzo[ij]quinolin-en]-2,4-oxazolidinedione |
| 06/16/2011 | US20110142717 Emissive sensors and devices incorporating these sensors |
| 06/15/2011 | EP2331539A2 1,3,4,6,7,11b-hexahydro-benzo[alpha]quinolizines for the treatment of hyperkinetic movement and related disorders |
| 06/15/2011 | EP2331508A2 Substituted berbines and processes for their synthesis |
| 06/15/2011 | CN102093345A Method for separating out dehydrogenized turkey corn by applying silicagel column chromatography |
| 06/14/2011 | US7960398 Potent inhibitors of TNF activity |
| 06/08/2011 | CN102086197A Protoberberine derivative with insulin-sensitizing activity and application thereof |
| 06/07/2011 | US7956201 Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one |
| 06/01/2011 | EP2326643A2 Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| 05/26/2011 | WO2011060867A1 Nitrogen-containing condensed heterocyclic compounds for oleds |
| 05/24/2011 | CA2537066C Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
| 05/19/2011 | WO2011058766A1 Aryl carboxamide derivatives as ttx-s blockers |
| 05/19/2011 | US20110118300 Glucose metabolism modulating compounds |
| 05/18/2011 | CN102060853A Method for separating alkaloid by reversely two-way eluted pH-zone-refining counter-current chromatography |
| 05/12/2011 | WO2011057215A1 Novel inhibitors of hepatitis c virus replication |
| 05/12/2011 | US20110112077 Quinolizidinone m1 Receptor Positive Allosteric Modulators |
| 05/10/2011 | CA2433158C Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
| 05/04/2011 | EP2315766A1 Octahydroquinolizines for antidiabetic treatment |
| 05/04/2011 | CN102040604A Fibriuretinin synthesis method |
| 05/04/2011 | CN102040603A Brominated N-o-methoxycarbonylbenzyl tetrahydroberberine and application thereof in treatment of hyperlipidemia |
| 04/27/2011 | CN102030746A Preparation method and application of 9-bit substituent double-functional group berberine derivatives |
| 04/27/2011 | CN101113149B Aliphatic organic acid salt of berberine type alkaloid and preparation method and usage thereof |
| 04/26/2011 | US7932382 Amide substituted heterocylic compound; anticarcinogen; inducing apoptotic cell death, sensitizing cells to inducers of apoptosis |
| 04/20/2011 | CN101497624B Bridged triphenyl amine compound, and use in electrophosphorescent device |
| 04/13/2011 | CN102015710A Azatricyclic antibiotic compounds |
| 04/13/2011 | CN101028343B Total alkaloid of meadowrue corydalis and its purification and medicinal composition |
| 04/05/2011 | US7919622 Intermediates for fluorinated tetrabenazine carbinol compounds imaging agents and probes |
| 03/31/2011 | WO2011035434A1 Gallium complex anti microbial compounds, compositions, uses and methods |
| 03/30/2011 | CN101998956A Fluorinated dihydrotetrabenazine ether imaging agents and probes |
| 03/23/2011 | CN101537193B Vesicle monoamine transporter target bound drug and preparation method thereof |
| 03/23/2011 | CN101161652B Quinolizine derivatives having antibacterial activity |
| 03/22/2011 | US7910738 Intermediates for alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
| 03/22/2011 | US7908735 Method and installation means for installing an electrical machine |
| 03/17/2011 | WO2011031744A1 Antibacterial fluoroquinolone analogs |
| 03/17/2011 | WO2010144937A3 Intermediates for the preparation of octahydroquinolizines |
| 03/16/2011 | CN101985447A Resolution method of tetrabenazine |
| 03/16/2011 | CN101985446A Method for synthesizing (+/-)-9-O-demethyl-alpha-dihydrotetrabenazine |
| 03/16/2011 | CN101985445A Method for preparing coptisine from coptis mixed alkaloid based on common basic structural characteristic |
| 03/15/2011 | CA2315117C Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission |
| 03/08/2011 | US7902364 Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
| 03/01/2011 | US7897770 Fluorinated dihydrotetrabenazine ether imaging agents and probes |
| 03/01/2011 | US7897769 Intermediates for fluorinated dihydrotetrabenazine ether imaging agents and probes |
| 03/01/2011 | US7897768 Method for making tetrabenazine compounds |
| 03/01/2011 | US7897634 Pyrazoles for the treatment of obesity and other CNS disorders |
| 03/01/2011 | US7897610 Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction |
| 03/01/2011 | US7897607 Cyclic compounds |
| 03/01/2011 | US7897589 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 02/24/2011 | US20110046145 Quinolizidinone M1 Receptor Positive Allosteric Modulators |
| 02/23/2011 | CN101978962A Medicinal composition for colon cancer and method for preparing effective monomers thereof |
| 02/17/2011 | US20110039877 Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis |
| 02/16/2011 | CN101973991A Preparation method of fibrauretine |
| 02/16/2011 | CN101973990A Method for separating dehydrocorydaline by pH-zone-refining countercurrent chromatography |
| 02/09/2011 | CN101970433A Gamma secretase modulators |
| 02/01/2011 | US7879875 such as 6-(2,4-difluorophenyl)-1-[2-fluoro-5-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]-2H-quinolizin-2-one, used as antipyretics, analgesics, or in the treatment of arthritis, osteoarthritis, eczema, psoriasis and vision defects |
| 01/27/2011 | WO2011009714A2 Benzoquinolizinium salt derivatives as anticancer agents |
| 01/27/2011 | CA2767463A1 Benzoquinolizinium salt derivatives as anticancer agents |
| 01/20/2011 | US20110015222 Benzoquinolizinium salt derivatives as anticancer agents |
| 01/20/2011 | US20110015201 Hedgehog pathway antagonists and methods of use |
| 01/20/2011 | US20110015180 Chemokine receptor antagonists |
| 01/19/2011 | CN101948469A Method for synthesizing berberine citrate |
| 01/13/2011 | WO2011006000A1 Berberine derivatives useful for modulating lipid levels and their methods of synthesis |
| 01/12/2011 | EP1987006B1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 01/11/2011 | US7868172 2-(hetero)-aryl substituted tetrahydroquinoline derivatives |
| 01/06/2011 | US20110003824 Caspase Inhibitors and Uses Thereof |
| 01/06/2011 | US20110003808 Octahydroquinolizines for antidiabetic treatment |
| 01/05/2011 | EP2268636A1 Gamma secretase modulators |
| 01/05/2011 | EP2268280A2 Quinolizidinone m1 receptor positive allosteric modulators |
| 01/05/2011 | CN101935334A Berberine glycyrrhetinic acid enantiomeric salts and preparation method and application thereof |
| 01/05/2011 | CN101935319A Berberine organic acid salt, berberine organic acid salt inclusion compound and preparation methods thereof |
| 12/29/2010 | EP2266967A1 Intermediates for the preparation of octahydroquinolizines |
| 12/29/2010 | CN101928285A Method for extracting major alkaloids from rhizoma coptidis |
| 12/28/2010 | US7858781 inflammatory conditions, allergies, autoimmune diseases, chronic pain, graft rejection, cancers which involve leukocyte filtration, stenosis or restenosis, atherosclerosis, rheumatoid arthritis, osteoarthritis; e.g. 4-Isobutoxy-1H-indole-2-carboxylic acid [4-(2-azepan-1-yl-ethyl)-phenyl]-amide |
| 12/23/2010 | WO2010145206A1 Preparation methods of optical isomers of stepholidine or its derivatives and intermediates thereof |
| 12/22/2010 | CN101921270A Mangiferin berberine salt, preparation method thereof and use thereof |
| 12/16/2010 | US20100317690 Treatment of protein folding disorders |
| 12/15/2010 | CN101918402A Octahydroquinoli zines for antidiabetic treatment |
| 12/08/2010 | EP2257551A2 Azatricyclic antibiotic compounds |
| 12/08/2010 | CN101906101A Rotundine crystal B-type solid matter and preparation method as well as applications |
| 12/08/2010 | CN101906100A Rotundine crystalline C-type solid substance and preparation method as well as application |
| 12/01/2010 | CN101153039B 13, 13a- dihydro berberine derivant and pharmaceutical composition |
| 11/25/2010 | US20100298372 Gamma secretase modulators |
| 11/24/2010 | EP2252151A1 Quinolizidinone m1 receptor positive allosteric modulators |
| 11/24/2010 | CN101195627B New application of benzo [C] phenanthridine and protopine in producing overriding resistant bacterium medicament |
| 11/18/2010 | US20100292478 Process of preparing a radioactive compound containing a fluorine-18 isotope |
| 11/18/2010 | US20100292476 Berberrubine Derivatives Having Antifungal Activities |
| 11/17/2010 | CN101889013A Fluoroalkyl tetrabenazine carbinol compounds as imaging agents and probes |